We used serial-sectioned pancreatic cancer microarrays for multiple immunofluorescent labeling of major components of the tumor microenvironment, including α-SMA, CD68, CD8, CD20, and CD11C [33, 34]. This evidence concerns the gene ITGAX and familial pancreatic carcinoma.